APA (7th ed.) Citation

T, N., N, H., N, I., S, S., A, N., M, B., . . . R, H. (2026). CIO-IAA is a dual ETA/ETB receptor antagonist that suppresses endothelin-1-induced macrophage activation and inflammatory signaling. Biochemical pharmacology, 254(Pt 3), 118517. https://doi.org/10.1016/j.bcp.2026.118517

Chicago Style (17th ed.) Citation

T, Nguyen, et al. "CIO-IAA Is a Dual ETA/ETB Receptor Antagonist That Suppresses Endothelin-1-induced Macrophage Activation and Inflammatory Signaling." Biochemical Pharmacology 254, no. Pt 3 (2026): 118517. https://doi.org/10.1016/j.bcp.2026.118517.

MLA (9th ed.) Citation

T, Nguyen, et al. "CIO-IAA Is a Dual ETA/ETB Receptor Antagonist That Suppresses Endothelin-1-induced Macrophage Activation and Inflammatory Signaling." Biochemical Pharmacology, vol. 254, no. Pt 3, 2026, p. 118517, https://doi.org/10.1016/j.bcp.2026.118517.